Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Insulinoma D007340 28 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Sarcoma 180 D012510 21 associated lipids
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Heart Failure D006333 36 associated lipids
Pulmonary Edema D011654 23 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Melanoma D008545 69 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Asthma D001249 52 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Proteinuria D011507 30 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Psoriasis D011565 47 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Nerve Degeneration D009410 53 associated lipids
Hypertension D006973 115 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Hyperalgesia D006930 42 associated lipids
Anaphylaxis D000707 35 associated lipids
Thrombocytopenia D013921 15 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Cardiomyopathies D009202 10 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenoma D000236 40 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Vascular Diseases D014652 16 associated lipids
Ovarian Diseases D010049 5 associated lipids
Anemia D000740 21 associated lipids
Glioblastoma D005909 27 associated lipids
Fabry Disease D000795 4 associated lipids
Influenza, Human D007251 11 associated lipids
Retinal Detachment D012163 10 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Atherosclerosis D050197 85 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Insulin Resistance D007333 99 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Endotoxemia D019446 27 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Acute Lung Injury D055371 33 associated lipids
Sensation Disorders D012678 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Neuralgia D009437 28 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Lung Injury D055370 14 associated lipids
Teratocarcinoma D018243 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Ileus D045823 3 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Niemann-Pick Disease, Type C D052556 1 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Wang F and Fishman DA Lysophosphatidic acid and invasion. 2009 Cancer Treat. Res. pmid:19763441
Kawamori T et al. Role for sphingosine kinase 1 in colon carcinogenesis. 2009 FASEB J. pmid:18824518
Rohatagi S et al. Use of an exposure-response model to aid early drug development of an oral sphingosine 1-phosphate receptor modulator. 2009 J Clin Pharmacol pmid:18948412
Satoh Y et al. Regulation by sphingolipids of the fate of FRTL-5 cells. 2009 J. Biochem. pmid:18953023
Michaelson LV et al. Functional characterization of a higher plant sphingolipid Delta4-desaturase: defining the role of sphingosine and sphingosine-1-phosphate in Arabidopsis. 2009 Plant Physiol. pmid:18978071
Jo SK et al. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury. 2009 Kidney Int. pmid:18971925
Wang L and Dudek SM Regulation of vascular permeability by sphingosine 1-phosphate. 2009 Microvasc. Res. pmid:18973762
Sun X et al. Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement. 2009 Microvasc. Res. pmid:19323978
Beech DJ et al. TRPC channel lipid specificity and mechanisms of lipid regulation. 2009 Cell Calcium pmid:19324410
Hayashi H et al. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19325137
Annabi B et al. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. 2009 Mol. Carcinog. pmid:19326372
Boyce BF Sphingosine-1 phosphate: a new player in osteoimmunology. 2009 Dev. Cell pmid:19289077
Yamane D et al. Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. 2009 J. Biol. Chem. pmid:19293152
Green DS et al. Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy. 2009 J. Virol. pmid:19297493
Yu H et al. Roles of extracellular and intracellular sphingosine 1-phosphate in cell migration. 2009 Genes Cells pmid:19371379
Milara J et al. Sphingosine-1-phosphate increases human alveolar epithelial IL-8 secretion, proliferation and neutrophil chemotaxis. 2009 Eur. J. Pharmacol. pmid:19285497
Huang YL et al. Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P1) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells. 2009 J. Biochem. pmid:19692429
Antoon JW et al. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells. 2009 J. Med. Chem. pmid:19694470
Zhao J et al. Phosphotyrosine protein dynamics in cell membrane rafts of sphingosine-1-phosphate-stimulated human endothelium: role in barrier enhancement. 2009 Cell. Signal. pmid:19755153
Crousillac S et al. Sphingosine-1-phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells. 2009 J. Neurophysiol. pmid:19776367
Igarashi J et al. Transforming growth factor-beta1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells. 2009 Am. J. Physiol., Cell Physiol. pmid:19710365
Stamer WD et al. Sphingosine-1-phosphate effects on the inner wall of Schlemm's canal and outflow facility in perfused human eyes. 2009 Exp. Eye Res. pmid:19715693
Li C et al. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. 2009 Am. J. Pathol. pmid:19729475
Hait NC et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. 2009 Science pmid:19729656
Czech B et al. The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. 2009 Biochem. Biophys. Res. Commun. pmid:19720050
Mochizuki N [Discovery of S1P transporter may uncover the unidentified S1P-regulated signal in circulation, immunity, and bone metabolism]. 2009 Tanpakushitsu Kakusan Koso pmid:19764473
Zhao YD et al. Bone marrow progenitor cells induce endothelial adherens junction integrity by sphingosine-1-phosphate-mediated Rac1 and Cdc42 signaling. 2009 Circ. Res. pmid:19696411
Yamamura T [Molecular target drug development for curing multiple sclerosis]. 2009 Brain Nerve pmid:19697881
Ranty ML et al. Ceramide production associated with retinal apoptosis after retinal detachment. 2009 Graefes Arch. Clin. Exp. Ophthalmol. pmid:18958490
Young N et al. Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. 2009 Mol. Cancer Res. pmid:19147534
Weis N et al. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. 2009 Mol. Biol. Cell pmid:19129475
Li MH et al. S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. 2009 Cancer Lett. pmid:19131156
Gérard A et al. The Rac activator Tiam1 controls efficient T-cell trafficking and route of transendothelial migration. 2009 Blood pmid:19139083
Berdyshev EV et al. FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. 2009 J. Biol. Chem. pmid:19119142
Vogel P et al. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. 2009 PLoS ONE pmid:19119317
Roztocil E et al. Mechanisms of sphingosine-1-phosphate-induced akt-dependent smooth muscle cell migration. 2009 Surgery pmid:19081473
Evindar G et al. Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists. 2009 Bioorg. Med. Chem. Lett. pmid:19081720
Lagadari M et al. Sphingosine-1-phosphate inhibits the cytotoxic activity of NK cells via Gs protein-mediated signalling. 2009 Int. J. Oncol. pmid:19082500
Yonesu K et al. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. 2009 Biochem. Pharmacol. pmid:19150609
Frias MA et al. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. 2009 Cardiovasc. Res. pmid:19151362
Liao JJ et al. Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor. 2009 FASEB J. pmid:19158154
Jang C et al. Angiopoietin-2 exocytosis is stimulated by sphingosine-1-phosphate in human blood and lymphatic endothelial cells. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19112163
Bergelin N et al. Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. 2009 Endocrinology pmid:19116345
Malchinkhuu E et al. Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid--induced migration by isoproterenol in glioma cells. 2009 Mol. Biol. Cell pmid:19864456
Morris AJ et al. Blood relatives: dynamic regulation of bioactive lysophosphatidic acid and sphingosine-1-phosphate metabolism in the circulation. 2009 Trends Cardiovasc. Med. pmid:19818950
Tachikawa M et al. Lysophospholipids enhance taurine release from rat retinal vascular endothelial cells under hypoosmotic stress. 2009 Microvasc. Res. pmid:19804786
Kimber I et al. Langerhans cell migration: not necessarily always at the center of the skin sensitization universe. 2009 J. Invest. Dermatol. pmid:19603050
Pyne NJ et al. New aspects of sphingosine 1-phosphate signaling in mammalian cells. 2009 Adv. Enzyme Regul. pmid:19534035
Price MM et al. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. 2009 FASEB J. pmid:19535686
Nixon GF Sphingolipids in inflammation: pathological implications and potential therapeutic targets. 2009 Br. J. Pharmacol. pmid:19563535
Taniguchi K et al. Sprouty4 deficiency potentiates Ras-independent angiogenic signals and tumor growth. 2009 Cancer Sci. pmid:19493272
Daum G et al. Sphingosine 1-phosphate: a regulator of arterial lesions. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19592471
Jung ID et al. FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration. 2009 Cell. Signal. pmid:19632319
Martin JL et al. Potentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. 2009 J. Biol. Chem. pmid:19633297
Trifilieff A et al. Role of sphingosine-1-phosphate (S1P) and the S1P(2) receptor in allergen-induced, mast cell-dependent contraction of rat lung parenchymal strips. 2009 Naunyn Schmiedebergs Arch. Pharmacol. pmid:19636535
Wacker BK et al. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2. 2009 Stroke pmid:19644058
Miranda GE et al. Sphingosine-1-phosphate is a key regulator of proliferation and differentiation in retina photoreceptors. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19357361
Vessey DA et al. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. 2009 Am. J. Physiol. Heart Circ. Physiol. pmid:19648253
Ohno Y et al. Palmitoylation of the sphingosine 1-phosphate receptor S1P is involved in its signaling functions and internalization. 2009 Genes Cells pmid:19619245
Florey O and Haskard DO Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions. 2009 J. Immunol. pmid:19620297
Weigert A et al. Regulation of macrophage function by sphingosine-1-phosphate. 2009 Immunobiology pmid:19625101
Rütti S et al. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. 2009 Endocrinology pmid:19628574
Rapizzi E et al. Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 2009 Cell. Mol. Life Sci. pmid:19662499
Haberberger RV et al. Role of sphingosine kinase 1 in allergen-induced pulmonary vascular remodeling and hyperresponsiveness. 2009 J. Allergy Clin. Immunol. pmid:19665772
Kim CH Reining in FoxP3(+) regulatory T cells by the sphingosine 1-phosphate-S1P1 axis. 2009 Immunol. Cell Biol. pmid:19652661
Yin H et al. Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. 2009 J. Biol. Chem. pmid:19286662
Ader I et al. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy. 2009 Cancer Res. pmid:19383898
Greenspon J et al. Sphingosine-1-phosphate protects intestinal epithelial cells from apoptosis through the Akt signaling pathway. 2009 Dig. Dis. Sci. pmid:18654850
Malemud CJ The discovery of novel experimental therapies for inflammatory arthritis. 2009 Mediators Inflamm. pmid:20339519
Xie B et al. Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. 2009 J. Cell. Physiol. pmid:18781584
Wetter JA et al. Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation. 2009 J Biomol Screen pmid:19726785
Pyne S et al. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. 2009 Cell. Signal. pmid:18768158
Zebol JR et al. The CCT/TRiC chaperonin is required for maturation of sphingosine kinase 1. 2009 Int. J. Biochem. Cell Biol. pmid:18775504
Foster DJ et al. Muscarinic receptor regulation of osmosensitive taurine transport in human SH-SY5Y neuroblastoma cells. 2009 J. Neurochem. pmid:19012745
Okajima F et al. Anti-atherogenic actions of high-density lipoprotein through sphingosine 1-phosphate receptors and scavenger receptor class B type I. 2009 Endocr. J. pmid:18753704
Jenne CN et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. 2009 J. Exp. Med. pmid:19808259
Snider AJ et al. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. 2009 FASEB J. pmid:18815359
Long DA and Price KL Sphingosine kinase-1: a potential mediator of renal fibrosis. 2009 Kidney Int. pmid:19789541
Heo K et al. Sphingosine 1-phosphate induces vascular endothelial growth factor expression in endothelial cells. 2009 BMB Rep pmid:19874715
Zhao M et al. [The effects of Sphing-1-phosphate(S1P) on the potassium channel of the ventricular myocytes]. 2009 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21186617
Jongsma M et al. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)). 2009 Br. J. Pharmacol. pmid:19309361
Garcia JG Concepts in microvascular endothelial barrier regulation in health and disease. 2009 Microvasc. Res. pmid:19232241
Igarashi J and Michel T Sphingosine-1-phosphate and modulation of vascular tone. 2009 Cardiovasc. Res. pmid:19233865
Sattler K and Levkau B Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. 2009 Cardiovasc. Res. pmid:19233866
Ishii M et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. 2009 Nature pmid:19204730
Zhang ZY et al. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis. 2009 Neuropathol. Appl. Neurobiol. pmid:19207263
Gillies L et al. The sphingosine 1-phosphate receptor 5 and sphingosine kinases 1 and 2 are localised in centrosomes: possible role in regulating cell division. 2009 Cell. Signal. pmid:19211033
Hla T and Im DS Cell biology. The ABCs of lipophile transport. 2009 Science pmid:19213902
Thathiah A et al. The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. 2009 Science pmid:19213921
Gaengel K et al. Endothelial-mural cell signaling in vascular development and angiogenesis. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19164813
Benamer N et al. Molecular and functional characterization of a new potassium conductance in mouse ventricular fibroblasts. 2009 J. Mol. Cell. Cardiol. pmid:19166858
Scherer M et al. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. 2009 Clin. Chem. pmid:19325012
Wadgaonkar R et al. Differential regulation of sphingosine kinases 1 and 2 in lung injury. 2009 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:19168577
Reines I et al. Topical application of sphingosine-1-phosphate and FTY720 attenuate allergic contact dermatitis reaction through inhibition of dendritic cell migration. 2009 J. Invest. Dermatol. pmid:19194476
Kim RH et al. Export and functions of sphingosine-1-phosphate. 2009 Biochim. Biophys. Acta pmid:19268560
Shimizu M et al. Effects of synthetic sphingosine-1-phosphate analogs on cytosolic phospholipase A2alpha-independent release of arachidonic acid and cell toxicity in L929 fibrosarcoma cells: the structure-activity relationship. 2009 J. Pharmacol. Sci. pmid:19276615
Limaye V et al. Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. 2009 Cell. Mol. Biol. Lett. pmid:19238330
Limaye V et al. The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cells. 2009 Cell. Mol. Biol. Lett. pmid:19238331
Schnitzer SE et al. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. 2009 Mol. Cancer Res. pmid:19240180
Xu Y et al. Lipid generation and signaling in ovarian cancer. 2009 Cancer Treat. Res. pmid:19763440